Skip to content
Bills from the 2021–22 session

Senate Bill 753

Prohibiting certain practices relating to insurance coverage of clinician-administered drugs

Stopped in committee

It had a but no committee vote, so it never came up for a vote. To try again, a lawmaker would have to start a new bill.

  1. Introduced, passed

    Dec 17, 2021

  2. Committee, stopped here

    Stopped here. It had a hearing but no committee vote.

  3. Senate vote, not reached

  4. Assembly vote, not reached

  5. Governor, not reached

  6. Law, not reached

Latest entry in the official record, Mar 15, 2022: “Failed to pass pursuant to ⁠”

It sat with the Senate Committee on Insurance, Licensing and Forestry.

Read the bill

Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.

What it would have done

Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.

This bill prohibits certain practices relating to clinician-administered drugs under the state's insurance unfair marketing and trade practices law. The bill defines “clinician-administered drug” as an outpatient prescription drug, other than a vaccine, that, due to medical necessity, cannot reasonably be self-administered by the patient or an individual assisting the patient and is typically administered by an authorized health care provider in a physician's office, hospital outpatient department, or other clinical setting. Under the bill, an insurer offering a health benefit plan, a pharmacy benefit manager, or an agent of the insurer or pharmacy benefit manager may not do any of the following:

1. Refuse to authorize, approve, or pay a participating provider for providing a covered clinician-administered drug and related services to an enrollee, policyholder, or insured.

Read the full summary

2. Condition, deny, restrict, refuse to authorize or approve, or reduce payment to a participating provider for a covered clinician-administered drug and related services when all criteria for medical necessity are met because the provider obtains the drug from an entity that is not selected by the plan. Also prohibited are health benefit plan designs that prevent participating providers from receiving reimbursement for a covered clinician-administered drug and any related service at an applicable rate as specified in the contract.

3. Impose coverage or benefit limitations, or require an enrollee, policyholder, or insured to pay an additional fee, higher copay or coinsurance, second copay or coinsurance, or penalty when obtaining a clinician-administered drug from an authorized health care provider or pharmacy.

4. Require an enrollee, policyholder, or insured to pay an additional fee, higher copay or coinsurance, second copay or coinsurance, or other form of a price increase for a clinician-administered drug when the drug is not dispensed by a pharmacy or acquired from an entity that is selected by the plan.

5. Interfere with an enrollee's, policyholder's, or insured's right to choose to obtain a clinician-administered drug from a participating provider or pharmacy of choice.

6. Limit or exclude coverage for a clinician-administered drug when not dispensed by a pharmacy or acquired from an entity selected by the plan when the drug would otherwise be covered.

7. Require a pharmacy to dispense a clinician-administered drug directly to an enrollee, policyholder, insured, or the insured's agent with the intention that the individual will transport the drug to a health care provider for administration.

8. Require or encourage the dispensing of a clinician-administered drug to an enrollee, policyholder, or insured in a manner that is inconsistent with the federal Drug Supply Chain Security Act.

9. Require that a clinician-administered drug be dispensed or administered to an enrollee, policyholder, or insured in the residence of the enrollee, policyholder, or insured or require the use of an infusion site external to the office or clinic of the enrollee's, policyholder's, or insured's provider.

Under the bill, a participating provider is a provider who is under contract with a defined network plan, preferred provider plan, or limited service health organization to provide health care services, items, or supplies to enrollees of the plan or organization or a clinic, hospital outpatient department, or pharmacy under the common ownership or control of the provider.

Who's behind it

20 senators are its ⁠. 11 are Democrats and 9 are Republicans.

62 more lawmakers ⁠.

See all 82 names

Authors (20)

Signed on in support (62)

What happened

  1. Mar 15, 2022

    The session ended, and the bill died with it.

  2. Jan 20, 2022

    The committee held a public hearing.

  3. Jan 6, 2022 to Jan 18, 2022

    1 more representative and 1 senator signed on in support.

  4. Dec 17, 2021

    Sent to the Senate Committee on Insurance, Licensing and Forestry.

  5. Dec 17, 2021

    Introduced in the Senate.

See the official record, word for word
  1. Dec 17, 2021 · Senate

    Introduced by Senators Darling, Marklein, Erpenbach, Bernier, Bewley, Carpenter, Cowles, Feyen, Jacque, Johnson, Nass, Petrowski, Pfaff, Ringhand, Roys, Smith, L. Taylor, Wirch, Wanggaard and Agard; cosponsored by Representatives Kurtz, Swearingen, Goyke, James, Petryk, Summerfield, Andraca, Baldeh, Behnke, Billings, Bowen, Brandtjen, Callahan, Conley, Considine, Dittrich, Doyle, Drake, Duchow, Edming, Emerson, Gundrum, Haywood, Hintz, Kerkman, Kitchens, Knodl, Krug, Macco, Magnafici, B. Meyers, Milroy, Moses, Mursau, L. Myers, Neubauer, Novak, Ohnstad, Oldenburg, Ortiz-Velez, Plumer, Pope, Riemer, J. Rodriguez, Rozar, Schraa, Shankland, Shelton, Sinicki, Skowronski, Snodgrass, Snyder, Spiros, Spreitzer, Stubbs, Tranel, Thiesfeldt, Vining, Vruwink, Wichgers and Tusler

  2. Dec 17, 2021 · Senate

    Read first time and referred to Committee on Insurance, Licensing and Forestry

  3. Jan 6, 2022 · Senate

    Representative Doyle withdrawn as a cosponsor

  4. Jan 6, 2022 · Senate

    Representative McGuire added as a cosponsor

  5. Jan 18, 2022 · Senate

    Senator Larson added as a coauthor

  6. Jan 20, 2022 · Senate

    Public hearing held

  7. Mar 15, 2022 · Senate

    Failed to pass pursuant to Senate Joint Resolution 1

Terms on this page

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

More in the glossary

Public hearing

A meeting where anyone can speak to a committee about a bill, or send written comments.

More in the glossary

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1. More in the glossary

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis. More in the glossary

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor. More in the glossary

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor. More in the glossary

From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

Public hearing

A meeting where anyone can speak to a committee about a bill, or send written comments.

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor